X0306 4 2018-02-20 0 0000860730 HCA Healthcare, Inc. HCA 0001377791 Hall Charles J ONE PARK PLAZA NASHVILLE TN 37203 0 1 0 0 Group President Common Stock 2018-02-20 4 M 0 20504 17.33 A 62048 D Common Stock 2018-02-20 4 S 0 20504 101.40 D 41544 D Common Stock 2018-02-21 4 M 0 20371 17.33 A 61915 D Common Stock 2018-02-21 4 M 0 12500 21.35 A 74415 D Common Stock 2018-02-21 4 M 0 10000 22.10 A 84415 D Common Stock 2018-02-21 4 S 0 13621 101.40 D 70794 D Common Stock 2018-02-21 4 S 0 15757 101.0662 D 55037 D Common Stock 2018-02-21 5 G 0 E 4950 0.00 D 50087 D Non-Qualified Stock Option (right to buy) 17.33 2018-02-20 4 M 0 20504 0.00 D 2021-11-02 Common Stock 20504 16996 D Non-Qualified Stock Option (right to buy) 17.33 2018-02-21 4 M 0 3375 0.00 D 2021-11-02 Common Stock 3375 34125 D Non-Qualified Stock Option (right to buy) 17.33 2018-02-21 4 M 0 16996 0.00 D 2021-11-02 Common Stock 16996 0 D Non-Qualified Stock Option (right to buy) 21.35 2018-02-21 4 M 0 12500 0.00 D 2012-11-02 2021-11-02 Common Stock 12500 0 D Non-Qualified Stock Option (right to buy) 22.10 2018-02-21 4 M 0 10000 0.00 D 2021-11-02 Common Stock 10000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.03 to $101.161, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets. Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. The option vested in three equal annual installments beginning on November 2, 2013. The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets. /s/ Natalie Harrison Cline, Attorney-in-Fact 2018-02-22